Navigation Links
Combination Therapy More Effective for Treating Lower Urinary Tract Symptoms

tamsulosin reported treatment benefit by week 12, compared with 62 percent of patients receiving placebo, 65 percent of patients receiving tolterodine ER, or 71 percent of patients receiving tamsulosin. Neither group receiving monotherapy demonstrated significant differences vs. placebo in percentages of patients reporting treatment benefit.

The symptoms of urgency urinary incontinence, urgency, and 24-hour and nocturnal urination frequency were also significantly improved by week 12 in the group receiving tolterodine ER plus tamsulosin vs. placebo but not in the tamsulosin group. In the tolterodine ER group, only urgency urinary incontinence episodes per 24 hours were significantly reduced at week 12. The International Prostate Symptom Score and quality-of-life scores were significantly improved by week 12 among patients receiving tolterodine ER plus tamsulosin. All interventions were well tolerated.

"The results of this study demonstrate that some men bothered by lower urinary tract symptoms, including bladder diary-documented overactive bladder symptoms, might not respond to monotherapy with either ?-receptor antagonists or antimuscarinic agents. Treatment with tolterodine ER plus tamsulosin resulted in statistically and clinically significant treatment benefit. Similarly low incidences of acute urinary retention were observed in all treatment groups, and there were no significant differences in maximum urinary flow rate or postvoid residual volume between any 2 groups," the authors conclude.

Source-Newswise
'"/>




Page: 1 2

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
(Date:12/1/2008)...Patient satisfaction scores at,outpatient health ... report,from Press Ganey Associates, Inc. The 20...on American Health Care cites increased competitio... patient services. The report,includes responses... than,1,200 outpatient care facilities nationwide...
(Date:12/1/2008)...e availability of a portable eight-slice computed ...ignificantly increase the number of stroke victims...Results of the study, conducted at North Shore Med... will be presented today at the annual meeting of ... , "The hospital,s acquisition of a portable CT ...
(Date:12/1/2008)...nection between second-hand smoke and coronary hea...s passed to reduce such passive smoking, exposures... January 2009 issue of the American Journal of Pr...y of California, San Francisco, Partners Healthcar...d the CHD Policy Model to better predict future tr...
(Date:12/1/2008)...en their DNA is damaged, in a process known as cel...m leading to unregulated cell division and therefo... week,s issue of PLoS Biology , has found that wh...nto their surrounding environment. This causes inf...development of age-related diseases including, iro...
Breaking Medicine News(10 mins):Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2Health News:Escape cancer, but age sooner? The dark side of the tumor suppressing process 2
...n a major step toward cloning pigs whose hearts, l... humans. Such organs would save the lives of thous...plants because of the shortage of human organs.// ...created the sheep Dolly, scientists say they produ...
...ty during pregnancy can increase a mother's risk o...at women who were very anxious// in the last three...oural problems. Lead researcher Professor Vivette...told that this only applied to women who had extre...
...lion over-the-counter drugs each year to treat rou...more and more drugs have made the switch from pres...icans, particularly senior citizens, misuse over-t...ll. Consumers have also complained that words like...
...nts with certain drugs helps them do a better job ...have been cleared surgically. But a new report sug...rs found that stents coated with a derivative of t...ivision - failed to keep blood vessels open in the...
Other Medicine News:Health News: Pig cloning for organs, 2
(Date:12/1/2008)...AGO, Dec. 2 A study has... new technique for imaging the breast, is not affe...l status, two factors that limit the effectiveness...er. Results will be presented today at the annual ...ca (RSNA). , , "The ability of PEM to dete...
(Date:12/1/2008)...sphatasia Treated With ENB-0040 at Children,s Hosp... MONTREAL, Dec. 1 Enobia Pharma, ...veloping novel therapeutics for serious bone disor...t in its clinical program for hypophosphatasia was... Therapy (ERT) with ENB-0040 for the treatment of ...
(Date:12/1/2008)...eduled for Tuesday, December 9 at 11:00 am ET to D... SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire...aq: SNSS ), a biopharmaceutical company focused ...cology therapeutics, today announced new data from...a (AML) will be presented during the 50th American...
(Date:11/28/2008)... November 28 German biotech compan...ecialized HIV monitoring and,AIDS patient follow-...es. In,the year 2008, 2.5 million patient tests h...highly affordable "CyFlow" system, supporting alre...DS. Due to introduction of the,Partec innovation,...
Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2CareAnalyzer From DST Health Solutions Helps Health Plans Improve Care Management and Quality for Members 28102 1CareAnalyzer From DST Health Solutions Helps Health Plans Improve Care Management and Quality for Members 28102 2Many Breast Cancer Patients Are Not Receiving Most Advanced Breast Conserving Surgical Techniques New Study Finds 28099 1Many Breast Cancer Patients Are Not Receiving Most Advanced Breast Conserving Surgical Techniques New Study Finds 28099 2Many Breast Cancer Patients Are Not Receiving Most Advanced Breast Conserving Surgical Techniques New Study Finds 28099 3 What Boomers Need to Know About Digestion 3B Enzymatic Therapy 26apos 3Bs CompleteGest1 Renew targets special digestive issues 28096 1 What Boomers Need to Know About Digestion 3B Enzymatic Therapy 26apos 3Bs CompleteGest1 Renew targets special digestive issues 28096 2Celebrity Cosmetic Dentist to Guest Co Host New National Day Time Talk Show 28093 1Celebrity Cosmetic Dentist to Guest Co Host New National Day Time Talk Show 28093 2
.../PRNewswire/ -- LigoCyte,Pharmaceuticals presented...with their influenza virus-like particles (VLPs),i...nge study. The,company,s data were presented by Dr...ne development, at the Tenth Annual Conference on,...ion of Infectious,Diseases in Baltimore. , The cur...
..., 2007 - Biogen Idec (NASDAQ: BIIB),and Elan Corpo...ata,from the TOUCH Prescribing Program(TM) and TYG...revious clinical studies of,TYSABRI(R) (natalizuma...he American Academy of Neurology in Boston, MA wer...s a sustained treatment,effect on clinical relapse...
Other Medicine Technology:LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic,Protection Against Influenza Challenge With Virus-Like Particle,Immunization 2Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 2Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 3Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 4Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 5Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 6
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: